All episodes (n=1835) | Patients with T1DM (n=1015) | Patients with T2DM (n=664) | p Value | |
---|---|---|---|---|
Median age (years) | 61 (44–75) | 48 (35–61) | 75 (68–81) | <0.0001 |
Females (%) | 732 (40%) | 323 (32%) | 336 (51%) | <0.0001 |
Pretreatment CBG (mmol/L) | 1.85 (±0.72) | 1.76 (±0.72) | 1.96 (±0.68) | <0.0001 |
Post-treatment CBG (mmol/L) | 6.30 (±2.66) | 6.41 (±2.71) | 6.15 (±2.59) | 0.0494 |
Mean HbA1c (mmol/mol) | 65.0 (±17.8) | 67.5 (±16.4) | 61.6 (±19.0) | <0.0001 |
Insulin use | 1600 (87%) | 1015 (100%) | 448 (69%) | |
Treatment given | ||||
Food and drink | 640 (35%) | 314 (31%) | 272 (41%) | <0.001 |
IV Glucose | 531 (29%) | 294 (29%) | 187 (28%) | 0.722 |
Glucagon | 609 (33%) | 379 (37%) | 187 (28%) | <0.001 |
None | 22 (1%) | 14 (1%) | 6 (1%) | 0.38 |
Transported to hospital | 123 (7%) | 40 (4%) | 59 (9%) | 0.0018 |
Lives alone | 463 (25%) | 221 (21%) | 199 (30%) | <0.0001 |
Data are presented as absolute numbers (percentages), median (IQR) or mean (SD).
CBG, capillary blood glucose; HbA1c, glycated hemoglobin; IV, intravenous; T1DM, type 1 diabetes; T2DM, type 2 diabetes.